Activation of Nod1 and Nod2 induces innate immune responses of prostate epithelial cells

Prostate

Volumn 72, Issue 12, 2012, Pages 1351-1358

  Kang, Min Jung ^a,b   Heo, Sook Kyoung ^a   Song, Eun Jung ^a   Kim, Dong Jae ^c   Han, Seung Yun ^d   Han, Ju Hee ^e   Kim, Bo Yeon ^b   Park, Jong Hwan ^a,b  

^a Konyang University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Konyang University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

cyclooxygenase 2; innate immune response; Nod1; Nod2; prostate epithelial cells

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; MALE; MICE; MICE, INBRED C57BL; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84864290278     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22483     Document Type: Article

References (38)

1. Takeuchi O, Akira S,. Pattern recognition receptors and inflammation. Cell 2010; 140 (6): 805-820.
2. Erridge C,. Endogenous ligands of TLR2 and TL R4: Agonists or assistants? J Leukoc Biol 2010; 87 (6): 989-999.
3. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA,. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 2008; 59: 343-359. (Pubitemid 351287942)
4. Inohara N, Chamaillard M, McDonald C, Nunez G,. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74: 355-383. (Pubitemid 40995511)
5. Franchi L, Warner N, Viani K, Nunez G,. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009; 227 (1): 106-128.
6. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, Inohara N, Nunez G,. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007; 179 (1): 514-521. (Pubitemid 46986568)
7. Scott MJ, Chen C, Sun Q, Billiar TR,. Hepatocytes express functional NOD1 and NOD2 receptors: A role for NOD1 in hepatocyte CC and CXC chemokine production. J Hepatol 2010; 53 (4): 693-701.
8. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G, Inohara N,. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 2008; 27 (2): 373-383. (Pubitemid 351161652)
9. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S,. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009; 10 (10): 1073-1080.
10. Collins MM, Stafford RS, O'Leary MP, Barry MJ,. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159 (4): 1224-1228. (Pubitemid 28172801)
11. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ,. Prevalence of a physician-assigned diagnosis of prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998; 51 (4): 578-584. (Pubitemid 28186210)
12. Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I,. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002; 167 (3): 1363-1366. (Pubitemid 34132094)
13. Domingue GJ Sr, Hellstrom WJ,. Prostatitis. Clin Microbiol Rev 1998; 11 (4): 604-613. (Pubitemid 28497564)
14. Krieger JN, Nyberg L Jr, Nickel JC,. NIH consensus definition and classification of prostatitis. JAMA 1999; 282 (3): 236-237. (Pubitemid 29343164)
15. Murphy AB, Macejko A, Taylor A, Nadler RB,. Chronic prostatitis: Management strategies. Drugs 2009; 69 (1): 71-84.
16. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O'Brien AD,. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun 2001; 69 (10): 6515-6519. (Pubitemid 32885218)
17. Pei Z, Lin D, Song X, Li H, Yao H,. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 2008; 254 (1): 20-27.
18. Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H, Kunishima Y, Matsukawa M, Takahashi S, Shibata K, Tsukamoto T, Kuroki Y,. Prostate cell lines secrete IL-8 in response to Mycoplasma hominis through Toll-like receptor 2-mediated mechanism. Prostate 2006; 66 (4): 386-391. (Pubitemid 43346949)
19. Di JM, Pang J, Pu XY, Zhang Y, Liu XP, Fang YQ, Ruan XX, Gao X,. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet 2009; 192 (2): 60-67.
20. Celada A, Gray PW, Rinderknecht E, Schreiber RD,. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med 1984; 160 (1): 55-74. (Pubitemid 14089780)
21. Di JM, Pang J, Sun QP, Zhang Y, Fang YQ, Liu XP, Zhou JH, Ruan XX, Gao X,. Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells. Mol Biol Rep 2010; 37 (4): 1849-1855.
22. Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB,. Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 2010; 184 (5): 2297-2304.
23. Sugawara Y, Uehara A, Fujimoto Y, Kusumoto S, Fukase K, Shibata K, Sugawara S, Sasano T, Takada H,. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006; 85 (6): 524-529. (Pubitemid 43945490)
24. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL,. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5 (11): 1166-1174. (Pubitemid 39549631)
25. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J,. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 2006; 281 (4): 2005-2011. (Pubitemid 43845788)
26. Uehara A, Fujimoto Y, Fukase K, Takada H,. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 2007; 44 (12): 3100-3111. (Pubitemid 46610510)
27. Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM,. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J Cell Physiol 2006; 209 (2): 241-252. (Pubitemid 44484613)
28. Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y,. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 2009; 160 (2): 297-304.
29. Lu H, Ouyang W, Huang C,. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4 (4): 221-233.
30. Hodge DR, Hurt EM, Farrar WL,. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41 (16): 2502-2512. (Pubitemid 41540626)
31. Drott JB, Alexeyev O, Bergstrom P, Elgh F, Olsson J,. Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiol 2010; 10: 126.
32. Uehara A, Takada H,. Synergism between TLRs and NOD1/2 in oral epithelial cells. J Dent Res 2008; 87 (7): 682-686.
33. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Nunez G,. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 2007; 178 (4): 2380-2386. (Pubitemid 46233437)
34. Kis B, Snipes JA, Isse T, Nagy K, Busija DW,. Putative cyclooxygenase-3 expression in rat brain cells. J Cereb Blood Flow Metab 2003; 23 (11): 1287-1292. (Pubitemid 37409791)
35. Jain S, Chakraborty G, Raja R, Kale S, Kundu GC,. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 2008; 68 (19): 7750-7759.
36. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR,. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 2000; 60 (16): 4629-4637. (Pubitemid 32103650)
37. Nithipatikom K, Isbell MA, Lindholm PF, Kajdacsy-Balla A, Kaul S, Campell WB,. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 2002; 19 (7): 593-601. (Pubitemid 35454569)
38. van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, Mengin-Lecreulx D, Playford RJ,. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol 2005; 35 (8): 2471-2476. (Pubitemid 41179768)